Mercer Global Advisors
AARD

Mercer Global Advisors’s Aardvark Therapeutics AARD Stock Holding History

Mercer Global Advisors’s Portfolio AARD Stock Details AARD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66K Buy
+11,464
New +$53.6K ﹤0.01% 4132

Other funds holding AARD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
SHIM
Stone House Investment Management Tunkhannock, Pennsylvania $752M AUM 20.1% 1-Year Est. Return

Mercer Global Advisors's AARD Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Aardvark Therapeutics (AARD) in Q2 2026: 11,464 shares worth $66K. The stake represents ﹤0.01% of the portfolio and ranks #4132 among its holdings.

27 funds tracked by Wall St. Rank hold AARD as of Q2 2026.

  • Mercer Global Advisors held 11,464 shares of Aardvark Therapeutics worth $66K as of Q2 2026.
  • Aardvark Therapeutics was a new Mercer Global Advisors position in Q2 2026.
  • Aardvark Therapeutics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #4132 holding.
  • 27 funds tracked by Wall St. Rank held Aardvark Therapeutics as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.